[Tardive dyskinesia after low doses of neuroleptics and attempts at treatment]

On the example of a 63-year-old neurotic patient dependent on alcohol and anxiolytic drugs the author draws attention to the risk of the development of a tardive dyskinesia after the long-term administration of "neurotic doses" of neuroleptics to non-psychotic patients. The author emphasizes the greater danger in the group of patients dependent on alcohol. He describes an attempt of concurrent treatment of neurosis, tardive dyskinesia and hypertension by a non-selective beta-blocker metopranolol (Trimepranol Spofa) administered for eight months. This drug was according to the author's information administered for the first time in tardive dyskinesia. It seems that it improves tardive dyskinesia in much smaller doses than anxiety and sleep disorders.